BSE filing, NSE: MITSU. Summary written from the filing by ALFA Finder's alert engine.
Mitsu Chem Plast Ltd: key numbers
- Share price
- ₹206.40
- Market cap
- ₹280.2 Cr
- Revenue (annual)
- ₹350.2 Cr
- Net profit (annual)
- ₹15.62 Cr
- P/E (TTM)
- 12.2×Sector 45.0×
- Promoter holding
- 67.77%-0.02% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mitsu Chem Plast Ltd
All →Mitsu Chem Plast Other Announcement
Mitsu Chem Plast reported that its statutory auditor, Gokhale & Sathe, converted into Gokhale & Sathe LLP effective 27 August 2026. The engagement and tenure remain unchanged.
Mitsu Chem Plast Investor Presentation: Key Takeaways
H1FY27 revenue Rs 19,095 Lakhs (+7% YoY), EBITDA Rs 2,738 Lakhs at 14% margin, PAT Rs 1,484 Lakhs (+365%). Strategy shifts toward hospital furniture and IBC.
Mitsu Chem Plast Q2 FY27 Results: Net Profit ₹6.1 Cr, Up 221.1% YoY
Mitsu Chem Plast Ltd reported revenue from operations of ₹95.8 Cr (+3.7% YoY) and net profit of ₹6.1 Cr (+221.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹6.1 Cr · +221.1% YoY
Mitsu Chem Plast Board Meeting Date
Mitsu Chem Plast will hold a board meeting on 31 October 2026 to consider unaudited results for the quarter and half year ended September 2026. The trading window stays closed until 48 hours after results are announced.
Mitsu Chem Plast Management Change
Mitsu Chem Plast disclosed the resignation of Haresh Sanghvi as its Secretarial Auditor, effective October 26, 2026. No material reason or adverse remark was cited.
Mitsu Chem Plast Convertible Warrants
Mitsu Chem Plast allotted 10 lakh fully convertible warrants at Rs. 151 each, aggregating to Rs. 15.10 Crore. These warrants are convertible into equity shares.
- Value
- ₹15.10 Cr
Other results update announcements
All →Rainbow Childrens Medicare Results Update
Rainbow Children's Medicare reported Q2 FY27 revenue of Rs. 5,480 Mn, up 23% YoY, with PAT of Rs. 839 Mn. Nellore and Guntur hospitals commenced operations during the quarter.
- hospital beds
- 120.0 beds
Sacheerome Results Update
Sacheerome reported H1 FY27 total income of Rs 8,592 Lakh, up 9.84%, and PAT up 12.38%. Its YEIDA facility began trial production in September 2026.
Studds Accessories Results Update
Studds Accessories disclosed Key Performance Indicators for the six months ended Sep 30, 2026 and fiscal 2026. Standalone revenue from operations was ₹349.41 Crore for the six months, up 15.55% year-on-year.
National Securities Depository Results Update
NSDL reported Q2 FY27 standalone total income growth of 11.7% and H1 FY27 growth of 13.3%. Consolidated net profit rose 10.9% in Q2 FY27 per the press release.
Accretion Nutraveda Results Update
Accretion Nutraveda released a half-year media release showing revenue up 109.35% to Rs 29.44 crore. EBITDA rose 88.03% and PAT rose 98.66%.
True Colors Results Update
True Colors Ltd issued a press release on its H1 FY27 results, showing revenue growth of about 21% year on year. Profit rose sharply on higher volumes.